title: What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'?
authors.affiliation: Centre for Addiction and Mental Health, Toronto, ON, Canada.
authors.forename: Doris E
authors.initials: DE
authors.lastname: Payer
authors.forename: Andy C
authors.initials: AC
authors.lastname: Dean
authors.forename: Isabelle
authors.initials: I
authors.lastname: Boileau
mesh_terms: D019969:Amphetamine-Related Disorders / Q000523:psychology*; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects*
chemical_list: D008694:Methamphetamine